Patient-controlled Sedation With Propofol and Remifentanyl for Endoscopic Retrograde Cholangiopancreatography (ERCP)
Status:
Completed
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
Background: Deep sedation with propofol and opioid is commonly used for endoscopic retrograde
cholangiopancreatography (ERCP), but is associated with increased morbidity and mortality.
Delivery of propofol and short-acting potent opioid analgesic using a self-administration
device (patient-controlled sedation, PCS) could be another option for this purpose.
Comparative studies with PCS for ERCP are lacking.The main objective of this prospective
randomized trial trial was to compare PCS with propofol/remifentanil to anaesthesiologist
managed propofol sedation during ERCP.
Phase:
Phase 4
Details
Lead Sponsor:
Helsinki University Central Hospital
Treatments:
Fentanyl Hypnotics and Sedatives Propofol Remifentanil